Harmony Biosciences Holdings Inc (HRMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 261,280 | 215,387 | 243,776 | 239,455 | 200,489 |
| Cost of Goods | 63,198 | 44,512 | 68,545 | 59,650 | 38,153 |
| Gross Profit | 198,082 | 170,875 | 175,231 | 179,805 | 162,336 |
| Operating Expenses | 108,964 | 134,096 | 137,219 | 114,968 | 114,309 |
| Operating Income | 89,316 | 37,291 | 38,557 | 65,487 | 48,180 |
| Interest Expense | 3,070 | 3,234 | 3,546 | 3,621 | 3,646 |
| Other Income | 7,019 | 5,630 | 5,749 | 5,624 | 5,103 |
| Pre-tax Income | 93,265 | 39,687 | 40,760 | 67,490 | 49,637 |
| Income Tax | 17,834 | 7,199 | 18,274 | 16,625 | 9,861 |
| Net Income Continuous | 75,431 | 32,488 | 22,486 | 50,865 | 39,776 |
| Net Income | $75,431 | $32,488 | $22,486 | $50,865 | $39,776 |
| EPS Basic Total Ops | 1.30 | 0.56 | 0.40 | 0.88 | 0.69 |
| EPS Basic Continuous Ops | 1.30 | 0.56 | 0.39 | 0.88 | 0.69 |
| EPS Diluted Total Ops | 1.28 | 0.55 | 0.38 | 0.87 | 0.68 |
| EPS Diluted Continuous Ops | 1.28 | 0.55 | 0.39 | 0.87 | 0.68 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.55 | 0.38 | 0.87 | 0.68 |
| EBITDA(a) | $95,013 | $43,190 | $45,865 | $71,280 | $53,857 |